medmix technology
Dominik Vonier
Head of Drug Delivery
14 November 2023
Providing innovative solutions to help people
live healthier and more confident lives
Disclaimer and other important notes
This presentation contains forward-looking statements that are based on management's current assumptions and expectations concerning future developments, including but not limited to, projections of financial developments, market activities or future performance of products and solutions, which therefore contain certain risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors, which could cause the actual results or performance to differ materially from the statements made in this presentation. These risks and other factors include, among others, general economic and geopolitical conditions, foreign exchange fluctuations, competitive product and pricing pressures, the effect of a pandemic or epidemic, a cyber event, a natural disaster or other force majeure, as well as regulatory developments and changes in tax regimes.
Alternative Performance Measures (APM)
All bridges from reported figures to APM can be found in the financial review of medmix' half-year report 2023 and all definitions of APM can be found in the APM section of medmix' annual report 2022.
2
medmix CONFIDENTIAL
medmix
Our aspiration, mission and vision
ASPIRATION
Be the global leader in high precision delivery devices for the healthcare, consumer & industrial end markets
MISSION
Provide innovative solutions to help millions of people live a healthier and more confident life
VISION
Deliver innovative, reliable and sustainable application solutions that contribute to a better world
medmix CONFIDENTIAL
medmix Key figures | Global | |
Our key figures | ||
footprint | ||
~2,600 | 14 | |
production, logistics | ||
& distribution | ||
employees | sites | |
22% | ||
477m | ||
CHF | ||
revenues in 2022 | adj. EBITDA | ~2.5bn |
~900 | margin in 2022 | products per year |
active patents
4
medmix CONFIDENTIAL
medmix Business Structure
Our segments
HEALTHCARE | CONSUMER AND INDUSTRIAL | |||
DRUG DELIVERY
SURGERY
DENTAL
INDUSTRY
BEAUTY
Award-winning, | Pioneer in bone cement | Gold standard in | Leading in industrial | Leading microbrush |
proprietary injection | mixing devices | dental mixing | mixing and dispensing | specialist |
pen platform | devices | device systems | ||
5 |
medmix CONFIDENTIAL
Drug Delivery - Overview
Haselmeier, a medmix brand
- Strong growth since acquisition in 2020 - re-positioning towards higher volumes
- Expanding product portfolio and ramping-up production capabilities
- Establish Haselmeier as preferred partner for our customers and their patients
- New autoinjector platform PiccoJect™ with distinct competitive advantages
- D-Flex™disposable pen, low investment, quick to market
- Portfolio ready for strong growth in obesity, growth disorders, biologics and biosimilars
6
medmix CONFIDENTIAL
Haselmeier Strategy: Complete and flexible offering
For our customers and their patients
Become the preferred partner for pen and autoinjector solutions
• Be the preferred partner for all complex solutions: nothing too complex or too small
- Focus on impactful and high-value indications, eg obesity, growth disorders, auto-immune
Leading specialist for highly customized solutions based on our technology platforms
• We offer a complete portfolio for both standard and flexible solutions
- We are the only full-service provider with locations in EU, US and India
7
medmix CONFIDENTIAL
Haselmeier Portfolio: Products and services
We cover all needs for our customers and their patients
Injection Pens | Autoinjectors | Digital Solutions | Services |
Customization:
Design & Development
Regulatory Affairs &
Quality Support
Final Assembly &
Packaging
8
medmix CONFIDENTIAL
Platforms tailored to customer and patients' needs
Product Platforms | Technology Platforms | |||||||
• | Lower capital expenditure | • | Flexible customization options | |||||
• | Lower development costs | • | Flexible financial models | |||||
• Faster time to market | • More flexible in regional sourcing | |||||||
9
medmix CONFIDENTIAL
Focus on PiccoJect™ autoinjector
Why an autoinjector?
- Simplifies at-home injection
- Ready to use
- Patient ease-of-use
- Safe
- Exact dosing
- Ideal for GLP-1 and biologics
10
medmix CONFIDENTIAL
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medmix Ltd. published this content on 14 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 November 2023 13:36:22 UTC.